Daclatasvir Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso Impurity 1 CAS NO: NA chemically represented as Dimethyl ((2S,2'S)-((2S,2'S)-([1,1'-biphenyl]-4,4'-diylbis(1-nitroso-1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-1,2-diyl))dicarbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso Impurity 1. We supply Daclatasvir Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143812 |
| CAS No | NA |
| Mol.F. | C14H13D3N4O2 |
| Mol.Wt. | 275.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143813 |
| CAS No | NA |
| Mol.F. | C14H13D3N4O2 |
| Mol.Wt. | 275.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143814 |
| CAS No | NA |
| Mol.F. | C11H18N2O3 |
| Mol.Wt. | 226.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143815 |
| CAS No | NA |
| Mol.F. | C18H21F6N3O4 |
| Mol.Wt. | 457.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143816 |
| CAS No | NA |
| Mol.F. | C19H21FN4O5 |
| Mol.Wt. | 404.4 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143817 |
| CAS No | NA |
| Mol.F. | C11H6F2N2O5 |
| Mol.Wt. | 284.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143817 |
| CAS No | NA |
| Mol.F. | C11H6F2N2O5 |
| Mol.Wt. | 284.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143818 |
| CAS No | NA |
| Mol.F. | C10H4F2N2O5 |
| Mol.Wt. | 270.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143819 |
| CAS No | NA |
| Mol.F. | C13H10F2N2O5 |
| Mol.Wt. | 312.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143820 |
| CAS No | NA |
| Mol.F. | C19H38N6O8 |
| Mol.Wt. | 478.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143821 |
| CAS No | NA |
| Mol.F. | C20H40N6O8 |
| Mol.Wt. | 492.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143822 |
| CAS No | NA |
| Mol.F. | C20H40N6O8 |
| Mol.Wt. | 492.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143823 |
| CAS No | NA |
| Mol.F. | C20H40N6O8 |
| Mol.Wt. | 492.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143824 |
| CAS No | NA |
| Mol.F. | C20H40N6O8 |
| Mol.Wt. | 492.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143825 |
| CAS No | NA |
| Mol.F. | C20H40N6O10 |
| Mol.Wt. | 524.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143826 |
| CAS No | NA |
| Mol.F. | C20H40N6O10 |
| Mol.Wt. | 524.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |